Matthew Keller
Stock Analyst at H.C. Wainwright
(0.06)
# 4,604
Out of 4,630 analysts
91
Total ratings
23.6%
Success rate
-22.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Keller
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GYRE Gyre Therapeutics | Reiterated: Buy | $18 | $6.67 | +169.87% | 11 | Aug 7, 2026 | |
| IFRX InflaRx | Reiterated: Buy | $8 | $1.84 | +334.78% | 11 | Aug 6, 2026 | |
| MCRB Seres Therapeutics | Reiterated: Buy | $12 | $4.87 | +146.41% | 3 | Aug 5, 2026 | |
| ACXP Acurx Pharmaceuticals | Reiterated: Buy | $31 | $1.54 | +1,912.99% | 11 | Aug 4, 2026 | |
| GALT Galectin Therapeutics | Reiterated: Buy | $11 | $3.45 | +218.84% | 10 | Jun 23, 2026 | |
| SXTP 60 Degrees Pharmaceuticals | Downgraded: Hold | n/a | $1.12 | - | 5 | May 20, 2026 | |
| GRI GRI Bio | Reiterated: Buy | $10 | $1.47 | +580.27% | 9 | May 14, 2026 | |
| KYNB Kyntra Bio | Reiterated: Buy | $43 | $7.27 | +491.47% | 13 | May 12, 2026 | |
| PHIO Phio Pharmaceuticals | Reiterated: Buy | $14 | $1.04 | +1,246.15% | 9 | May 8, 2026 | |
| ITRMF Iterum Therapeutics plc | Downgraded: Hold | n/a | $0.00001 | - | 5 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $24.39 | - | 4 | Oct 30, 2025 |
Gyre Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $18
Current: $6.67
Upside: +169.87%
InflaRx
Aug 6, 2026
Reiterated: Buy
Price Target: $8
Current: $1.84
Upside: +334.78%
Seres Therapeutics
Aug 5, 2026
Reiterated: Buy
Price Target: $12
Current: $4.87
Upside: +146.41%
Acurx Pharmaceuticals
Aug 4, 2026
Reiterated: Buy
Price Target: $31
Current: $1.54
Upside: +1,912.99%
Galectin Therapeutics
Jun 23, 2026
Reiterated: Buy
Price Target: $11
Current: $3.45
Upside: +218.84%
60 Degrees Pharmaceuticals
May 20, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.12
Upside: -
GRI Bio
May 14, 2026
Reiterated: Buy
Price Target: $10
Current: $1.47
Upside: +580.27%
Kyntra Bio
May 12, 2026
Reiterated: Buy
Price Target: $43
Current: $7.27
Upside: +491.47%
Phio Pharmaceuticals
May 8, 2026
Reiterated: Buy
Price Target: $14
Current: $1.04
Upside: +1,246.15%
Iterum Therapeutics plc
Mar 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.00001
Upside: -
Oct 30, 2025
Downgraded: Hold
Price Target: n/a
Current: $24.39
Upside: -